OĞUL, A. .; BÜYÜKŞIMŞEK, M. Prognostic role of inflammatory markers in hepatocellular cancer patients receiving sorafenib therapy. Medical Science and Discovery, [S. l.], v. 7, n. 5, p. 475–481, 2020. DOI: 10.36472/msd.v7i5.374. Disponível em: https://medscidiscovery.com/index.php/msd/article/view/374. Acesso em: 20 apr. 2024.